Menu

Experience

Matthew Hemington

    • Intersect ENT Acquires Fiagon 


    • Si-Bone: $92.5 Million Follow-On 


    • Intersect ENT Closes Convertible Offering 


    • 1Life Healthcare: $257.3 Million Follow-On 


    • Si-Bone Initial Public Offering  


    • Intersect ENT Initial Public Offering 


    • Scynexis Initial Public Offering  


    • Everspin Technologies Initial Public Offering  


    • 1Life Healthcare – $350 Million Investment by The Carlyle Group 


    • 1Life Healthcare Investment by The Carlyle Group 


    • CymaBay Therapeutics Initial Public Offerings 


    • Si-BONE Initial Public Offering 


    • Epocrates $293 Million Sale to athenahealth 


    • AKQA: Sale to WPP plc 


    • Instructure Sells to Thoma Bravo for $2 Billion 


    • 1Life Healthcare - $282 Million IPO 


    • 1Life Healthcare Inc. Closes Convertible Offering 


    • Thoma Bravo’s Instructure Agrees to Sell Employee Development Platform Bridge to Learning Technologies Group 


    • Achronix Agrees to SPAC Merger With ACE Convergence Acquisition 


Contact us

Back to top

© 2021 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.